Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

CYTRELLIS BIOSYSTEMS, INC.

US

Last updated September 17, 2026

Information

Country
US
Address
34 Commerce Way, Woburn, MA, 01801
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3020704367
DUNS Number
—

Catalogue (25)

DeviceModel / ReferenceRegistriesClassStatus
ellacor EL-SYS01
FDA UDI
Class IIActive
ellacor EL-CON02
FDA UDI
Class IIActive
Ellacor EL-HPC01
FDA UDI
Class IIActive
Ellacor EL-03N02
FDA UDI
Class IIActive
ellacor EL-CLP01
FDA UDI
Class IIActive
Ellacor EL-HPC02
FDA UDI
Class IIActive
Ellacor EL-HPC02-R
FDA UDI
Class IIActive
ellacor EL-KIT03
FDA UDI
Class IIActive
Ellacor EL-03N01
FDA UDI
Class IIActive
Ellacor EL-CON01-R
FDA UDI
Class IIActive
Ellacor EL-CCV01
FDA UDI
Class IIActive
ellacor EL-SYS02
FDA UDI
Class IIActive
Ellacor EL-03N02
FDA UDI
Class IIActive
Ellacor EL-03N02
FDA UDI
Class IIActive
Ellacor EL-CON02-R
FDA UDI
Class IIActive
Ellacor EL-03N01
FDA UDI
Class IIActive
Ellacor EL-FTS01
FDA UDI
Class IIActive
ellacor EL-KIT02
FDA UDI
Class IIActive
Ellacor EL-CCV01
FDA UDI
Class IIActive
ellacor EL-KIT01
FDA UDI
Class IIActive
Ellacor EL-FTS01-R
FDA UDI
Class IIActive
Ellacor EL-HPC01-R
FDA UDI
Class IIActive
Ellacor EL-CON01
FDA UDI
Class IIActive
Cytrellis Dermal Micro-Coring System K202517
FDA 510(k)
Class IIActive
ellacor System with Micro-Coring Technology K252752
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (2)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Jun 23, 2023Z-2393-2023—open, classified

Potential failure of a bearing adhesive joint that can occur due to an assembly issue of the X/Y stage of the handpiece. If a broken glue bond were to occur, it could cause an overlap of cores, potentially leading to prolonged healing and irregularities in patient skin texture post-treatment, and/or scarring

Apr 7, 2023Z-1648-2023—completed

Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring.